NYSE:BAX - Baxter International Stock Price, Price Target & More

$67.05 +0.07 (+0.10 %)
(As of 04/22/2018 04:00 PM ET)
Previous Close$67.05
Today's Range$66.76 - $67.40
52-Week Range$52.59 - $72.58
Volume2.67 million shs
Average Volume2.87 million shs
Market Capitalization$36.22 billion
P/E Ratio27.04
Dividend Yield0.95%
Beta0.8

About Baxter International (NYSE:BAX)

Baxter International logoBaxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:BAX
CUSIP07181310
Phone224-948-2000

Debt

Debt-to-Equity Ratio0.38%
Current Ratio2.57%
Quick Ratio2.05%

Price-To-Earnings

Trailing P/E Ratio27.04
Forward P/E Ratio24.12
P/E Growth1.83

Sales & Book Value

Annual Sales$10.56 billion
Price / Sales3.43
Cash Flow$3.9233 per share
Price / Cash17.09
Book Value$16.73 per share
Price / Book4.01

Profitability

EPS (Most Recent Fiscal Year)$2.48
Net Income$717 million
Net Margins6.79%
Return on Equity15.11%
Return on Assets8.18%

Miscellaneous

Employees47,000
Outstanding Shares540,140,000

How to Become a New Pot Stock Millionaire

Baxter International (NYSE:BAX) Frequently Asked Questions

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, February 20th. Investors of record on Friday, March 2nd will be paid a dividend of $0.16 per share on Monday, April 2nd. This represents a $0.64 dividend on an annualized basis and a yield of 0.95%. The ex-dividend date is Thursday, March 1st. View Baxter International's Dividend History.

How will Baxter International's stock buyback program work?

Baxter International declared that its board has authorized a share buyback plan on Wednesday, February 21st 2018, which authorizes the company to buyback $1,500,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company's leadership believes its shares are undervalued.

How were Baxter International's earnings last quarter?

Baxter International (NYSE:BAX) issued its quarterly earnings data on Thursday, February, 1st. The medical instruments supplier reported $0.64 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.59 by $0.05. The medical instruments supplier had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.77 billion. Baxter International had a return on equity of 15.11% and a net margin of 6.79%. The firm's revenue was up 4.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.57 earnings per share. View Baxter International's Earnings History.

When is Baxter International's next earnings date?

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for Baxter International.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its FY18 earnings guidance on Thursday, February, 1st. The company provided EPS guidance of $2.72-2.80 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.72. The company issued revenue guidance of +6-7% (Approx $11.2-11.3 billion), compared to the consensus revenue estimate of $11.10 billion.Baxter International also updated its Q1 guidance to $0.60-0.62 EPS.

What price target have analysts set for BAX?

16 Wall Street analysts have issued 12-month price targets for Baxter International's stock. Their predictions range from $62.00 to $80.00. On average, they expect Baxter International's share price to reach $70.9286 in the next year. View Analyst Ratings for Baxter International.

Who are some of Baxter International's key competitors?

Who are Baxter International's key executives?

Baxter International's management team includes the folowing people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 56)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 45)
  • Mr. Brik V. Eyre, Sr. VP & Pres of Americas (Age 54)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Global Bus.es (Age 47)
  • Mr. Scott Pleau, Sr. VP of Operations (Age 52)

Has Baxter International been receiving favorable news coverage?

Media headlines about BAX stock have trended somewhat positive this week, according to Accern. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Baxter International earned a daily sentiment score of 0.06 on Accern's scale. They also assigned news coverage about the medical instruments supplier an impact score of 46.72 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $67.05.

How big of a company is Baxter International?

Baxter International has a market capitalization of $36.22 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


MarketBeat Community Rating for Baxter International (BAX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  496 (Vote Outperform)
Underperform Votes:  422 (Vote Underperform)
Total Votes:  918
MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Baxter International (NYSE:BAX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
16 Wall Street analysts have issued ratings and price targets for Baxter International in the last 12 months. Their average twelve-month price target is $70.9286, suggesting that the stock has a possible upside of 5.78%. The high price target for BAX is $80.00 and the low price target for BAX is $62.00. There are currently 6 hold ratings, 9 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.692.692.672.50
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
5 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $70.9286$70.9286$68.3846$65.4167
Price Target Upside: 5.78% upside6.93% upside1.81% upside4.13% upside

Baxter International (NYSE:BAX) Consensus Price Target History

Price Target History for Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/20/2018Deutsche BankUpgradeHold -> Buy$80.00LowView Rating Details
2/6/2018CitigroupBoost Price TargetNeutral -> Neutral$66.00 -> $70.00MediumView Rating Details
2/2/2018Royal Bank of CanadaReiterated RatingHold$72.00MediumView Rating Details
2/2/2018BarclaysBoost Price TargetOverweight -> Overweight$73.00 -> $77.00MediumView Rating Details
2/2/2018BMO Capital MarketsBoost Price TargetOutperform -> Outperform$74.00 -> $77.00MediumView Rating Details
1/3/2018Raymond JamesUpgradeMarket Perform -> Outperform$73.00MediumView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform -> Outperform$71.00MediumView Rating Details
1/2/2018Bank of AmericaUpgradeNeutral -> BuyHighView Rating Details
1/2/2018JPMorgan ChaseUpgradeNeutral -> OverweightHighView Rating Details
10/26/2017Stifel NicolausReiterated RatingHold$65.00N/AView Rating Details
10/26/2017Morgan StanleyBoost Price TargetEqual Weight$59.00 -> $62.00N/AView Rating Details
10/15/2017CowenSet Price TargetHold$68.00N/AView Rating Details
7/28/2017UBSBoost Price TargetNeutral$57.00 -> $62.00LowView Rating Details
7/27/2017Leerink SwannReiterated RatingOutperform$67.00 -> $75.00LowView Rating Details
7/26/2017Cantor FitzgeraldSet Price TargetBuy$70.00MediumView Rating Details
5/16/2017Goldman SachsReiterated RatingConviction-Buy$71.00HighView Rating Details
10/13/2016Wells FargoInitiated CoverageOutperformN/AView Rating Details
8/15/2016ArgusReiterated RatingHoldN/AView Rating Details
6/13/2016Piper JaffrayReiterated RatingOverweight$60.00N/AView Rating Details
5/10/2016Credit Suisse GroupReiterated RatingHoldN/AView Rating Details
(Data available from 4/22/2016 forward)

Earnings

Baxter International (NYSE:BAX) Earnings History and Estimates Chart

Earnings by Quarter for Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) Earnings Estimates

2018 EPS Consensus Estimate: $2.78
2019 EPS Consensus Estimate: $3.10
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.61$0.62$0.62
Q2 20182$0.69$0.71$0.70
Q3 20182$0.71$0.74$0.73
Q4 20182$0.73$0.74$0.74
Q1 20191$0.71$0.71$0.71
Q2 20191$0.77$0.77$0.77
Q3 20191$0.79$0.79$0.79
Q4 20191$0.83$0.83$0.83

Baxter International (NYSE BAX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2018$0.64N/AView Earnings Details
2/1/2018Q4 2017$0.59$0.64$2.7652 billion$2.7740 billionViewListenView Earnings Details
10/25/2017Q3 2017$0.59$0.64$2.6634 billion$2.7070 billionViewN/AView Earnings Details
7/26/2017Q2 2017$0.57$0.63$2.5942 billion$2.6050 billionViewN/AView Earnings Details
4/26/2017Q1 2017$0.51$0.58$2.4309 billion$2.4750 billionViewN/AView Earnings Details
2/1/2017Q416$0.52$0.57$2.65 billion$2.65 billionViewListenView Earnings Details
10/25/2016Q316$0.45$0.56$2.67 billion$2.56 billionViewListenView Earnings Details
7/26/2016Q216$0.40$0.46$2.51 billion$2.60 billionViewListenView Earnings Details
4/26/2016Q116$0.29$0.36$2.35 billion$2.40 billionViewListenView Earnings Details
2/2/2016Q415$0.32$0.43$2.55 billion$2.60 billionViewListenView Earnings Details
10/27/2015Q315$0.29$0.41$2.46 billion$2.49 billionViewListenView Earnings Details
7/29/2015Q215$0.94$1.00$2.40 billion$3.90 billionViewListenView Earnings Details
4/23/2015Q115$0.88$1.00$3.70 billion$3.76 billionViewListenView Earnings Details
1/29/2015Q414$1.31$1.34$4.37 billion$4.47 billionViewListenView Earnings Details
10/16/2014Q314$1.31$1.31$4.21 billion$4.20 billionViewListenView Earnings Details
7/17/2014Q214$1.21$1.26$4.12 billion$4.30 billionViewListenView Earnings Details
4/17/2014Q114$1.10$1.19$3.88 billion$3.95 billionViewListenView Earnings Details
1/23/2014Q413$1.25$1.26$4.25 billion$4.40 billionViewListenView Earnings Details
10/17/2013Q313$1.19$1.19$3.82 billion$3.80 billionViewListenView Earnings Details
7/18/2013Q2 2013$1.13$1.16$3.70 billion$3.67 billionViewListenView Earnings Details
4/18/2013Q1 2013$1.04$1.05$3.49 billion$3.45 billionViewListenView Earnings Details
1/24/2013Q4 2012$1.26$1.26$3.72 billion$3.75 billionViewListenView Earnings Details
10/18/2012$1.14$1.14ViewN/AView Earnings Details
7/19/2012$1.11$1.12ViewN/AView Earnings Details
4/19/2012$1.00$1.01ViewN/AView Earnings Details
1/26/2012$1.17$1.17ViewN/AView Earnings Details
10/20/2011$1.08$1.09ViewN/AView Earnings Details
7/21/2011$1.02$1.07ViewN/AView Earnings Details
4/21/2011$0.93$0.98ViewN/AView Earnings Details
1/27/2011$1.10$1.11ViewN/AView Earnings Details
10/21/2010Q3 2010$0.97$1.01ViewN/AView Earnings Details
7/22/2010Q2 2010$0.92$0.93ViewN/AView Earnings Details
4/22/2010Q1 2010$0.93$0.93ViewN/AView Earnings Details
1/28/2010Q4 2009$1.03$1.03ViewN/AView Earnings Details
10/15/2009Q3 2009$0.96$0.98ViewN/AView Earnings Details
7/16/2009Q2 2009$0.94$0.96ViewN/AView Earnings Details
4/16/2009Q1 2009$0.81$0.83ViewN/AView Earnings Details
1/22/2009Q4 2008$0.89$0.91ViewN/AView Earnings Details
10/16/2008Q3 2008$0.82$0.88ViewN/AView Earnings Details
7/17/2008Q2 2008$0.81$0.85ViewN/AView Earnings Details
4/17/2008Q1 2008$0.72$0.74ViewN/AView Earnings Details
1/24/2008Q4 2007$0.74$0.76ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Baxter International (NYSE:BAX) Dividend Information

Baxter International pays an annual dividend of $0.64 per share, with a dividend yield of 0.95%. BAX's most recent quarterly dividend payment was Monday, April 2. Baxter International pays out 25.81% of its earnings out as a dividend.
Most Recent Dividend:4/2/2018
Annual Dividend:$0.64
Dividend Yield:0.95%
Dividend Growth:-34.00% (3 Year Average)
Payout Ratio:25.81% (Trailing 12 Months of Earnings)
23.02% (Based on This Year's Estimates)
20.38% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/20/2018Quarterly$0.160.95%3/1/20183/2/20184/2/2018
11/14/2017quarterly$0.160.99%11/30/201712/1/20171/2/2018
7/18/2017quarterly$0.161.03%8/30/20179/1/201710/2/2017
5/2/2017quarterly$0.161.14%5/31/20176/2/20177/3/2017
2/21/2017quarterly$0.131.04%3/1/20173/3/20174/3/2017
11/8/2016quarterly$0.131.12%11/30/201612/2/20161/3/2017
7/19/2016quarterly$0.131.11%8/31/20169/2/201610/3/2016
5/3/2016quarterly$0.131.15%6/1/20166/3/20167/1/2016
2/16/2016quarterly$0.11501.23%3/2/20163/4/20164/1/2016
11/11/2015quarterly$0.11501.21%12/2/201512/4/20151/4/2016
7/29/2015quarterly$0.11501.15%9/2/20159/4/201510/1/2015
5/5/2015quarterly$0.523.02%5/28/20156/1/20157/1/2015
2/17/2015quarterly$0.523.04%3/9/20153/11/20154/1/2015
11/11/2014quarterly$0.522.92%12/3/201412/5/20141/2/2015
7/22/2014quarterly$0.522.71%9/3/20149/5/201410/1/2014
5/5/2014quarterly$0.522.81%6/4/20146/6/20147/1/2014
2/18/2014quarterly$0.492.84%3/5/20143/7/20144/1/2014
11/12/2013quarterly$0.492.95%12/4/201312/6/20131/3/2014
7/23/2013quarterly$0.492.66%9/4/20139/6/201310/1/2013
5/6/2013quarterly$0.492.86%6/5/20136/7/20137/1/2013
2/19/2013quarterly$0.452.67%3/6/20133/8/20134/1/2013
(Data available from 1/1/2013 forward)

Insider Trades

Baxter International (NYSE BAX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.05%
Institutional Ownership Percentage: 85.52%
Insider Trading History for Baxter International (NYSE:BAX)
Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Baxter International (NYSE BAX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/2/2018Peter S HellmanDirectorSell3,760$64.74$243,422.4025,522View SEC Filing  
3/28/2018James R Gavin IIIDirectorSell18,750$64.56$1,210,500.0036,398View SEC Filing  
3/2/2018Carole J ShapazianDirectorSell4,990$66.05$329,589.50View SEC Filing  
1/2/2018Giuseppe AccogliSVPSell28,641$67.00$1,918,947.00View SEC Filing  
12/4/2017Jeanne K MasonSVPSell33,350$65.25$2,176,087.50124,609View SEC Filing  
11/6/2017Third Point LlcDirectorSell5,000,000$64.23$321,150,000.00View SEC Filing  
9/5/2017Thomas T StallkampDirectorSell8,920$62.28$555,537.6016,263View SEC Filing  
8/25/2017John D ForsythDirectorSell9,440$61.76$583,014.4032,444View SEC Filing  
8/24/2017Carole J ShapazianDirectorSell4,020$61.61$247,672.2013,868View SEC Filing  
8/17/2017Giuseppe AccogliSVPSell12,670$60.96$772,363.2033,286View SEC Filing  
5/23/2017Carole J ShapazianDirectorSell2,618$57.92$151,634.569,848View SEC Filing  
5/9/2017Carole J ShapazianDirectorSell3,760$55.89$210,146.4016,226View SEC Filing  
5/8/2017Brik V EyreSVPSell130,732$55.69$7,280,465.0849,966View SEC Filing  
4/10/2017Albert P L StrouckenDirectorSell4,280$52.80$225,984.0025,667View SEC Filing  
3/29/2017James R Gavin IIIDirectorSell4,280$51.72$221,361.6034,980View SEC Filing  
2/22/2017Peter S HellmanDirectorSell4,280$49.81$213,186.8024,420View SEC Filing  
2/8/2017John D ForsythDirectorSell4,280$48.35$206,938.0031,338View SEC Filing  
5/23/2016Jose E AlmeidaCEOBuy11,691$42.75$499,790.2511,691View SEC Filing  
5/2/2016John D ForsythDirectorSell1,887$44.38$83,745.0626,320View SEC Filing  
4/4/2016John D ForsythDirectorSell1,887$41.75$78,782.2526,315View SEC Filing  
3/14/2016James R Gavin IIIDirectorSell5,660$40.34$228,324.4033,432View SEC Filing  
2/17/2016Peter S. HellmanDirectorSell5,660$38.35$217,061.0017,520View SEC Filing  
2/11/2016Kornelis J. StormDirectorSell5,660$35.98$203,646.8019,191View SEC Filing  
5/22/2015Carole J ShapazianDirectorSell1,533$67.68$103,753.44View SEC Filing  
4/27/2015James R Gavin IIIDirectorSell4,830$71.06$343,219.80View SEC Filing  
7/25/2014Carole J ShapazianDirectorSell1,645$76.98$126,632.10View SEC Filing  
7/24/2014Thomas T StallkampDirectorSell8,300$76.82$637,606.00View SEC Filing  
7/9/2014Ludwig HantsonVPSell24,693$76.00$1,876,668.00View SEC Filing  
5/2/2014Carole ShapazianDirectorSell5,680$75.28$427,590.405,146View SEC Filing  
4/23/2014Kees StormDirectorSell5,760$72.45$417,312.0015,156View SEC Filing  
4/21/2014Blake DevittDirectorSell4,334$73.12$316,902.0816,541View SEC Filing  
3/27/2014Sebastian BufalinoVPSell21,600$75.10$1,622,160.006,275View SEC Filing  
9/12/2013Carole ShapazianDirectorSell1,941$71.58$138,936.785,111View SEC Filing  
8/1/2013Robert L Parkinson JrCEOSell725,750$73.33$53,219,247.50View SEC Filing  
7/26/2013David P ScharfVPSell55,438$73.79$4,090,770.02View SEC Filing  
7/25/2013James R Gavin IIIDirectorSell5,760$72.82$419,443.20View SEC Filing  
7/24/2013Carole J ShapazianDirectorSell4,320$73.58$317,865.60View SEC Filing  
7/22/2013Robert J HombachCFOSell47,452$73.95$3,509,075.40View SEC Filing  
7/16/2013Phillip L BatchelorVPSell5,850$73.00$427,050.00View SEC Filing  
5/22/2013Blake E DevittDirectorSell1,000$72.34$72,340.00View SEC Filing  
5/20/2013Sebastian J BufalinoVPSell24,000$73.75$1,770,000.00View SEC Filing  
5/17/2013Robert M DavisVPSell130,800$73.00$9,548,400.00View SEC Filing  
9/13/2012Michael J BaughmanVPSell11,500$61.00$701,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Baxter International (NYSE BAX) News Headlines

Source:
DateHeadline
[$$] Allied Healthcare lines up rescue plan[$$] Allied Healthcare lines up rescue plan
finance.yahoo.com - April 22 at 4:20 PM
 Analysts Expect Baxter International (BAX) Will Announce Quarterly Sales of $2.62 Billion Analysts Expect Baxter International (BAX) Will Announce Quarterly Sales of $2.62 Billion
www.americanbankingnews.com - April 21 at 4:20 AM
Baxter International (BAX) Rating Increased to Outperform at BMO Capital MarketsBaxter International (BAX) Rating Increased to Outperform at BMO Capital Markets
www.americanbankingnews.com - April 19 at 4:00 PM
Baxter International (BAX) Expected to Announce Earnings of $0.62 Per ShareBaxter International (BAX) Expected to Announce Earnings of $0.62 Per Share
www.americanbankingnews.com - April 19 at 11:15 AM
Baxter International (BAX) Set to Announce Earnings on ThursdayBaxter International (BAX) Set to Announce Earnings on Thursday
www.americanbankingnews.com - April 19 at 1:56 AM
Can Hospital-Products Unit Aid Baxter (BAX) in Q1 Earnings?Can Hospital-Products Unit Aid Baxter (BAX) in Q1 Earnings?
www.zacks.com - April 17 at 9:52 AM
Cantor Fitzgerald Reiterates "$70.00" Price Target for Baxter International (BAX)Cantor Fitzgerald Reiterates "$70.00" Price Target for Baxter International (BAX)
www.americanbankingnews.com - April 15 at 5:39 PM
Baxter International (BAX) Cut to "Buy" at BidaskClubBaxter International (BAX) Cut to "Buy" at BidaskClub
www.americanbankingnews.com - April 15 at 12:36 AM
Edited Transcript of BAX presentation 7-Mar-17 12:30pm GMTEdited Transcript of BAX presentation 7-Mar-17 12:30pm GMT
finance.yahoo.com - April 12 at 10:37 AM
Multiple Tornadoes Spotted In Fort Lauderdale, FloridaMultiple Tornadoes Spotted In Fort Lauderdale, Florida
www.msn.com - April 11 at 4:19 PM
Baxter International (BAX) Stock Rating Upgraded by Zacks Investment ResearchBaxter International (BAX) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 11 at 1:49 PM
Baxter International (BAX) Raised to "Strong-Buy" at BidaskClubBaxter International (BAX) Raised to "Strong-Buy" at BidaskClub
www.americanbankingnews.com - April 10 at 4:28 PM
Abbott Laboratories Goes Ex-Dividend on April 12, 2018Abbott Laboratories Goes Ex-Dividend on April 12, 2018
finance.yahoo.com - April 10 at 4:13 PM
Global Sterile Injectable Market Opportunities 2018: Novartis AG, Sanofi S.A, Johnson & Johnson, Baxter InternationalGlobal Sterile Injectable Market Opportunities 2018: Novartis AG, Sanofi S.A, Johnson & Johnson, Baxter International
www.marketwatch.com - April 10 at 10:05 AM
Baxter International (BAX) Receives "Hold" Rating from Royal Bank of CanadaBaxter International (BAX) Receives "Hold" Rating from Royal Bank of Canada
www.americanbankingnews.com - April 8 at 11:01 AM
Baxter International (BAX) PT Set at $68.00 by CowenBaxter International (BAX) PT Set at $68.00 by Cowen
www.americanbankingnews.com - April 7 at 12:23 PM
Zacks Investment Research Downgrades Baxter International (BAX) to HoldZacks Investment Research Downgrades Baxter International (BAX) to Hold
www.americanbankingnews.com - April 7 at 9:11 AM
Baxter International (BAX) Downgraded to "Hold" at Zacks Investment ResearchBaxter International (BAX) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 6 at 12:35 PM
Global Artificial Blood and Plasma Markets to 2027: Leading Players are Alliance Pharma., Baxter Healthcare, Northfield Lab, Sanguine Biosciences, and Therapure Biopharma ...Global Artificial Blood and Plasma Markets to 2027: Leading Players are Alliance Pharma., Baxter Healthcare, Northfield Lab, Sanguine Biosciences, and Therapure Biopharma ...
www.businesswire.com - April 5 at 8:50 AM
Insider Selling: Baxter International Inc (BAX) Director Sells 3,760 Shares of StockInsider Selling: Baxter International Inc (BAX) Director Sells 3,760 Shares of Stock
www.americanbankingnews.com - April 4 at 10:56 PM
Baxter International (BAX) PT Raised to $62.00 at Morgan StanleyBaxter International (BAX) PT Raised to $62.00 at Morgan Stanley
www.americanbankingnews.com - April 4 at 7:30 PM
Baxter International (BAX) Price Target Increased to $73.00 by Analysts at BarclaysBaxter International (BAX) Price Target Increased to $73.00 by Analysts at Barclays
www.americanbankingnews.com - April 4 at 6:54 PM
Baxter to Host First Quarter 2018 Financial Results Conference Call for InvestorsBaxter to Host First Quarter 2018 Financial Results Conference Call for Investors
finance.yahoo.com - April 4 at 5:13 PM
Baxter International Inc (BAX) Receives Consensus Recommendation of "Buy" from AnalystsBaxter International Inc (BAX) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - April 4 at 10:44 AM
$2.62 Billion in Sales Expected for Baxter International Inc (BAX) This Quarter$2.62 Billion in Sales Expected for Baxter International Inc (BAX) This Quarter
www.americanbankingnews.com - April 4 at 3:58 AM
Baxter International (BAX) Lifted to Buy at ValuEngineBaxter International (BAX) Lifted to Buy at ValuEngine
www.americanbankingnews.com - April 3 at 6:58 PM
Baxter International (BAX) Raised to Buy at Zacks Investment ResearchBaxter International (BAX) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - April 3 at 2:58 PM
Baxter International Inc. to Host Webcast of Annual Meeting of StockholdersBaxter International Inc. to Host Webcast of Annual Meeting of Stockholders
finance.yahoo.com - April 3 at 10:05 AM
 Brokerages Anticipate Baxter International Inc (BAX) to Announce $0.62 Earnings Per Share Brokerages Anticipate Baxter International Inc (BAX) to Announce $0.62 Earnings Per Share
www.americanbankingnews.com - April 2 at 9:10 AM
Bank of America Upgrades Baxter International (BAX) to BuyBank of America Upgrades Baxter International (BAX) to Buy
www.americanbankingnews.com - March 31 at 11:54 AM
Baxter International (BAX) Upgraded by JPMorgan Chase to OverweightBaxter International (BAX) Upgraded by JPMorgan Chase to Overweight
www.americanbankingnews.com - March 31 at 11:54 AM
Form 4 BAXTER INTERNATIONAL For: Mar 28 Filed by: STORM KORNELIS J.Form 4 BAXTER INTERNATIONAL For: Mar 28 Filed by: STORM KORNELIS J.
www.streetinsider.com - March 31 at 9:40 AM
Baxter International (BAX) Coverage Initiated at Evercore ISIBaxter International (BAX) Coverage Initiated at Evercore ISI
www.americanbankingnews.com - March 30 at 11:40 PM
Discussing BDX’s Recent Stock Price PerformanceDiscussing BDX’s Recent Stock Price Performance
finance.yahoo.com - March 30 at 4:16 PM
Baxter International Inc (BAX) Director James R. Gavin III Sells 18,750 SharesBaxter International Inc (BAX) Director James R. Gavin III Sells 18,750 Shares
www.americanbankingnews.com - March 30 at 4:14 PM
Baxter International (BAX) Rating Increased to Hold at Zacks Investment ResearchBaxter International (BAX) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - March 30 at 3:58 PM
Top Analyst Reports for Netflix, PNC Financial & MondelezTop Analyst Reports for Netflix, PNC Financial & Mondelez
finance.yahoo.com - March 29 at 4:13 PM
Baxter International Inc. -- Moodys upgrades Baxter International to Baa1 from Baa2, stable outlookBaxter International Inc. -- Moody's upgrades Baxter International to Baa1 from Baa2, stable outlook
finance.yahoo.com - March 29 at 4:13 PM
Baxter International (BAX) Downgraded by Zacks Investment Research to "Hold"Baxter International (BAX) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - March 29 at 11:24 AM
Why Should You Start Accumulating Baxter In 2018?Why Should You Start Accumulating Baxter In 2018?
seekingalpha.com - March 28 at 4:10 PM
Commit To Purchase Baxter International At $47.50, Earn 2.6% Using OptionsCommit To Purchase Baxter International At $47.50, Earn 2.6% Using Options
www.nasdaq.com - March 28 at 4:10 PM
Baxter International (BAX) Upgraded by Zacks Investment Research to BuyBaxter International (BAX) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - March 26 at 9:57 AM
Baxter International (BAX) Cut to "Hold" at ValuEngineBaxter International (BAX) Cut to "Hold" at ValuEngine
www.americanbankingnews.com - March 24 at 2:30 PM
Baxter International (BAX) Downgraded by Zacks Investment ResearchBaxter International (BAX) Downgraded by Zacks Investment Research
www.americanbankingnews.com - March 23 at 1:02 PM
Baxter (BAX) Closes Acquisition of RECOTHROM & PREVELEAK - NasdaqBaxter (BAX) Closes Acquisition of RECOTHROM & PREVELEAK - Nasdaq
www.nasdaq.com - March 22 at 4:24 PM
Baxter (BAX) Closes Acquisition of RECOTHROM & PREVELEAKBaxter (BAX) Closes Acquisition of RECOTHROM & PREVELEAK
www.zacks.com - March 22 at 9:42 AM
Here's Why You Should Invest in Baxter International NowHere's Why You Should Invest in Baxter International Now
finance.yahoo.com - March 20 at 4:21 PM
Baxter Completes Acquisition of RECOTHROM and PREVELEAK to ... - Business Wire (press release)Baxter Completes Acquisition of RECOTHROM and PREVELEAK to ... - Business Wire (press release)
www.businesswire.com - March 19 at 4:20 PM
What Investors Should Know about TMO’s DividendsWhat Investors Should Know about TMO’s Dividends
finance.yahoo.com - March 19 at 4:20 PM
Baxter International (BAX) Lifted to "Buy" at Zacks Investment ResearchBaxter International (BAX) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - March 19 at 11:15 AM

SEC Filings

Baxter International (NYSE:BAX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Baxter International (NYSE:BAX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Baxter International (NYSE BAX) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.